Document Detail


Comparison of different regimens of glucocorticoid replacement therapy in patients with hypoadrenalism.
MedLine Citation:
PMID:  16218046     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Since the optimal glucocorticoid replacement needs to avoid over and under treatment, the adequacy of different daily cortisone acetate (CA) doses was assessed in 34 patients with primary and central hypoadrenalism. The conventional twice CA 37.5 mg/day dose was administered to all patients (A regimen: 25 mg at 07:00 h, 12.5 mg at 15:00 h), while in 2 subgroups of 12 patients the dose was shifted on 2 thrice daily regimens (B: 25 mg at 07:00, 6.25 mg at 12: 00, 6.25 mg at 17:00; C: 12.5 mg, 12.5 mg, 12.5 mg). In other 12 patients the conventional dose was reduced to a thrice 25 mg/day administration (D regimen: 12.5 mg, 6.25 mg, 6.25 mg). In all patients, urinary free cortisol (UFC) excretion and cortisol day curves were evaluated. During the CA 37.5 mg administration, nadir cortisol levels were significantly higher with the thrice daily regimens (143 +/- 31 on B and 151 +/- 34 nmol/l on C) than with the conventional twice (85 +/- 16 nmol/l). Moreover, UFC, morning cortisol levels and mean cortisol day curves were similar in each group. Finally, during D regimen nadir cortisol levels were higher than in A and similar to B and C regimens. No difference in UFC and in cortisol day curves by reducing the CA dose was found. In conclusion, the thrice daily cortisone regimens, in which more physiological cortisol levels are achieved, perform better as replacement therapy. The administration of 25 mg/day CA confirms that replacement therapy is more adequate with a lower dose, particularly in patients with central hypoadrenalism.
Authors:
L Barbetta; C Dall'Asta; T Re; R Libè; E Costa; B Ambrosi
Related Documents :
9272106 - One microgram is the lowest acth dose to cause a maximal cortisol response. there is no...
3526986 - A study of isoetharine mesylate in patients with chronic bronchial asthma.
1321056 - In vivo and in vitro effects of glucocorticosteroids on arachidonic acid metabolism and...
7226906 - Salbutamol inhalation in chronic asthma bronchiale: dose aerosol vs jet nebulizer.
9272106 - One microgram is the lowest acth dose to cause a maximal cortisol response. there is no...
8052956 - The effects of transdermal estradiol and oral conjugated estrogens on haemostasis varia...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of endocrinological investigation     Volume:  28     ISSN:  0391-4097     ISO Abbreviation:  J. Endocrinol. Invest.     Publication Date:    2005 Jul-Aug
Date Detail:
Created Date:  2005-10-12     Completed Date:  2006-01-06     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7806594     Medline TA:  J Endocrinol Invest     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  632-7     Citation Subset:  IM    
Affiliation:
Endocrinology Unit, Department of Medical and Surgical Sciences, Istituto Policlinico San Donato, University of Milano, Milano, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenal Insufficiency / drug therapy*
Adult
Aged
Cortisone / administration & dosage,  analogs & derivatives,  therapeutic use
Drug Administration Schedule
Female
Glucocorticoids / administration & dosage*,  therapeutic use*
Hormone Replacement Therapy*
Humans
Hydrocortisone / blood,  urine
Male
Middle Aged
Chemical
Reg. No./Substance:
0/Glucocorticoids; 50-04-4/cortisone acetate; 50-23-7/Hydrocortisone; 53-06-5/Cortisone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women.
Next Document:  Role of intron 5 C/T polymorphism of the calcium sensing receptor gene in the regulation of the seru...